Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, ...
Research has already shown the psychedelic drug psilocybin eases depression, PTSD, and anxiety. Now researchers are working on deleting the hallucinations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback